Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article - Biomedical Research (2017) Volume 28, Issue 5

Roles of miR-16 in vascular endothelial injury in patients with coronary heart disease

Objective: This study is to detect miR-16 expression in peripheral blood of patients with Coronary Heart Disease (CHD), and explore the role of miR-16 in vascular endothelial injury.

Methods: Peripheral blood was collected from coronary patients. QRT-PCR was applied to detect miR-16 expression and autophagy related 14 (AGT14) mRNA expressions. After transfection with miR-16 inhibitor in vitro, the biological functions of miR-16 were detected in endothelial cells by CCK-8, apoptosis assay, and cell cycle analysis. Bioinformatics methods predicted that ATG14 was one of target genes regulated by miR-16. Dual luciferase assay was used to validate whether miR-16 directly regulated ATG14. Expression changes of ATG14, Beclin1 and microtubule-associated protein 1 light chain 3 beta (LC3B) were detected by Western blot.

Results: miR-16 expression was significantly increased in blood in CHD patients, and miR-16 expression was higher in patients with unstable angina than patients with stable angina (P<0.05), which indicated that miR-16 was related to the development of CHD. In vitro experimental results showed that miR-16 inhibited the proliferation and promoted apoptosis of endothelial cells significantly (P<0.05). Compared with control group, the percentage of cells in G1 phase in miR-16 inhibitor group significantly decreased (58.8 ± 3.51 vs. 40.7 ± 3.32) whereas the percentage of cells in S phase significantly increased (21.8 ± 1.62 vs. 32.7 ± 2.47) (P<0.05), indicating that miR-16 inhibited G1/S conversion of endothelial cells. The dual luciferase assay validated that miR-16 directly targeted ATG14. Western blot and qRT-PCR results demonstrated that expressions of Beclin1 and LC3B were repressed when miR-16 was over-expressed while were significantly increased after down-regulated miR-16. And, electronic microscopy showed that miR-16 inhibited the formation of autophagy bodies in endothelial cells.

Conclusion: MiR-16 expression was up-regulated in peripheral blood of patients with CHD. MiR-16 regulated ATG14 expression in endothelial cells. Thus, miR-16 may play a role in the development of vascular endothelial injury and CHD.

Author(s): Zheng Cao, Li Qian, Shen Wu

Abstract Full Text PDF